HBI Deals+Insights / M&A/IPOs

Singapore-based Fullerton to IPO

Singapore-based healthcare provider Fullerton has received approval to list on the Singapore stock exchange, but could its S$1.5bn (almost €1bn) valuation be too high?

We would welcome your thoughts on this story. Email your views to Ariane Jugieux or call 0207 183 3779.